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Structural Analyses of DNA Recognition
by the AML1/Runx-1 Runt Domain
and Its Allosteric Control by CBFb
Introduction
The promoter regions of most genes contain binding
sites for multiple transcription factors whose interac-
tions are essential for correct regulation of transcription.
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Such interactions include those between different tran-and Kazuhiro Ogata1,2,7,11
scription factors as well as those between subunits of1 Kanagawa Academy of Science and Technology
the same factor. In the case of some heterodimeric fac-(KAST)
tors (e.g., Jun/Fos and Myc/Max) both subunits bind to2 Department of Structural Biology
specific DNA sequences, and recent X-ray studies of3 Department of Urology
this type of protein have clarified the molecular mecha-4 Department of Pathology
nisms of their DNA binding (e.g., the “scissors grip” by5 Department of Biochemistry
the Fos-Jun heterodimer) (Glover and Harrison, 1995).Yokohama City University School of Medicine
On the other hand, some transcription factors consist3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004
of one subunit that binds to DNA and one that does not.Japan
In most cases of this type of protein, it remains unknown6 Protein Folding Group
how non DNA binding subunit contributes to DNA bind-National Institute of Bioscience
ing and whether the mechanism by which a non DNAand Human-Technology
binding subunit stimulates DNA binding is shared with1-1 Higashi, Tsukuba, Ibaraki 305-8566
different transcription factors. In this type, very littleJapan
structural information is available to date, e.g., GABPa-7 Bio-Crystallography Technology Division
GABPb-DNA complex (Batchelor et al., 1998). One well-8 Structural Biophysics Laboratory
studied example of this type of transcription factor isRIKEN Harima Institute / SPring-8
core binding factor (CBF), which functions as a hetero-1-1-1 Kouto, Mikazuki, Sayo, Hyogo 679-5148
dimer consisting of a DNA binding a subunit and a nonJapan
binding b subunit.9 Laboratory of Molecular Genetics
In mammals, CBF is considered to regulate severalRIKEN Tsukuba Institute
promoters of hematopoietic genes. These include cyto-10 CREST (Core Research for Evolutional Science
kines such as interleukin-3 (IL-3) and granulocyte-mac-and Technology) Research Project of JST (Japan
rophage colony-stimulating factor (GM-CSF); myeloidScience and Technology Corporation)
specific enzymes such as myeloperoxidase, neutrophil3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074
elastase, and granzyme B; and cell surface receptorsJapan
such as colony-stimulating factor-1 receptor (CSF-1R),
T cell receptor (TCR)a, TCRb, TCRg, TCRd, and CD3e
(Speck and Stacy, 1995; Lutterbach and Hiebert, 2000).
Three genes encode the CBFa subunits: Runx-1 (also
Summary called AML1, CBFA2, or PEBP2aB; here we use AML1/
Runx-1), Runx-2 (also called AML3, CBFA1, or PEB-
P2aA; here we use CBFA1/Runx-2) and Runx-3 (alsoThe core binding factor (CBF) heterodimeric transcrip-
called AML2, CBFA3, or PEBP2aC), whereas a singletion factors comprised of AML/CBFA/PEBP2a/Runx
gene encodes the common CBFb subunit (also calledand CBFb/PEBP2b subunits are essential for differen-
PEBP2b). CBFA1/Runx-2 is essential for osteoblast dif-tiation of hematopoietic and bone cells, and their mu-
ferentiation and bone development (Komori and Kishi-tation is intimately related to the development of acute
moto, 1998), and its haploinsufficiency results in cleido-leukemias and cleidocranial dysplasia. Here, we pre-
cranial dysplasia (CCD) in humans (Quack et al., 1999;sent the crystal structures of the AML1/Runx-1/
Zhou et al., 1999; Zhang et al., 2000). AML1/Runx-1 andCBFa(Runt domain)-CBFb(core domain)-C/EBPb(b-
CBFb are required for hematopoiesis in the fetal liverZip)-DNA, AML1/Runx-1/CBFa(Runt domain)-C/EBP-
and possibly the emergence of definitive hematopoieticb(bZip)-DNA, and AML1/Runx-1/CBFa(Runt domain)-
cells from hemogenic endothelia in the developing em-DNA complexes. The hydrogen bonding network
bryo (Speck et al., 1999). The AML1/Runx-1 and CBFbformed among CBFa(Runt domain) and CBFb, and
genes are positioned on chromosomes 21 and 16, re-CBFa(Runt domain) and DNA revealed the allosteric
spectively, and are frequently targeted by chromosomalregulation mechanism of CBFa(Runt domain)-DNA
translocation, inversion, and point mutations in acutebinding by CBFb. The point mutations of CBFa related
myeloid and lymphoid leukemias, blast crises in chronicto the aforementioned diseases were also mapped
myelogenous leukemia, and therapy-related acute my-and their effect on DNA binding is discussed.
eloid leukemias and myelodysplasias, which together
account for about 30% of human leukemias (Speck and
Stacy, 1995; Look, 1997; Rowley, 1998; Ito, 1999; Low-11 To whom correspondence should be addressed (e-mail: tahir@
enberg et al., 1999; Speck et al., 1999; Lutterbach andmed.yokohama-cu.ac.jp [T. H. T.], ogata@med.yokohama-cu.ac.jp
[K. O.]) Hiebert, 2000). In addition to such acquired leukemias,
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haploinsufficiency of AML1/Runx-1 is also associated with the structure of the former being classified as an
s-type immunoglobulin fold (Figures 2B, 2C, and 3A).with a familial platelet disorder with a propensity to de-
velop into acute myelogenous leukemia (FPD/AML) The present structures show that the Runt domain
recognizes specific bases in both the major and minor(Song, et al., 1999).
The CBFa-CBFb heterodimer recognizes the DNA grooves of the DNA, and that binding is accomplished
mainly using loops. The CBFb core domain interactsconsensus sequence, PyGPyGGTPy (Kamachi et al.,
1990; Melnikova et al., 1993; Speck and Stacy, 1995); with the CBFa Runt domain at a site distant from the
protein–DNA interface (Figures 1B and 1C). The DNACBFa directly interacts with specific bases, and CBFb
stabilizes the CBFa-DNA interaction (Ogawa et al., bends by about 208 around the last T of the CBF consen-
sus site (TGTGGTT), where a loop of the CBFa interacts1993). The region of CBFa responsible for DNA binding
and for heterodimerization, known as the Runt domain, with bases in the DNA minor groove (Figure 1C).
The mechanism by which C/EBPb recognizes the DNAexhibits remarkable sequence homology to two Dro-
sophila transcriptional regulators: Runt, which is involved will be described elsewhere (Tahirov et al., 2001). Con-
trary to earlier protein–protein and protein–DNA bindingin segmentation, sex determination, and neurogenesis,
and Lozenge, which is involved in eye development (Ka- assays (Zhang et al., 1996; Petrovick et al., 1998), analy-
ses of crystals of the CBFa-b-C/EBPb-DNA and CBFa-goshima et al., 1993, 1996; Ito, 1999). That the amino acid
sequences of the Runt domains exhibit .90% identity C/EBPb-DNA complexes revealed no direct interaction
between the C/EBPb basic leucine zipper domain andamong the three CBFa isoforms strongly suggests that
similar mechanisms govern their DNA binding and heter- the CBFa Runt domain or the CBFb core domain. It is
nonetheless important to mention that the presence ofodimerization.
Recently, NMR and X-ray diffraction were used to C/EBPb within the CBFa-b-C/EBPb-DNA and CBFa-C/
EBPb-DNA complexes prevents homodimerization ofobtain information about the structures of the CBFa
Runt domain part in the DNA-bound state, of the free CBFa, which is seen with the CBFa-CBFb (Warren et
al., 2000) and CBFa-DNA complexes.CBFb subunit, and of the CBFa-CBFb complex in the
DNA-free form (Berardi et al., 1999; Goger et al., 1999;
Huang et al., 1999; Nagata et al., 1999; Warren et al., CBFa-DNA Interactions
2000). However, due to a lack of information about the CBFa makes contact with the DNA at consensus se-
whole structures of CBFa-DNA and CBFa-CBFb-DNA quence 59-TGTGGTT-39 using three loop-containing re-
complexes, the structural basis of the most important gions: b3-L3, b9-L9, and b12-L12. The first and third
elements—DNA recognition by CBFa and the allosteric interact with the major groove, while the second inter-
regulation of CBFa-DNA binding by CBFb—remain un- acts with the minor groove (Figures 2B, 2D, and 2E).
clear. Three critical guanines (G18, G20, and G21) are each
Here, we present the three-dimensional structures ob- recognized by three arginine residues (Arg80 in b3 and
tained by X-ray crystallography of an AML1/Runx-1 (res- Arg174 and Arg177 in L12, respectively) forming bipartite
idues 60–182)-CBFb (residues 1–141)-C/EBPb (residues hydrogen bonds in the major groove. Asp171, which inter-
259–336)-DNA (26 bp) quarternary complex, an AML1/ acts with two consecutive cytosines (C219 and C209), also
Runx-1 (residues 60–182)-C/EBPb (residues 259–345)- makes a hydrogen bond with Arg174, thereby fixing the
DNA (26 bp) ternary complex, and an AML1/Runx-1 (resi- orientation of its guanidinium group for interaction with
dues 60–182)-DNA (16 bp) binary complex, which are the DNA. Lys83, which interacts with the sugar-phos-
abbreviated to CBFa-b-C/EBPb-DNA, CBFa-C/EBPb- phate backbone of the DNA, also binds to the guanidi-
DNA, and CBFa-DNA, respectively; our focus is on the nium group of Arg80, stabilizing its side chain conforma-
recognition of specific DNA sequences by CBFa and on tion in both cases via a water molecule. A229 is recognized
the mechanism by which CBFb facilitates DNA binding. by Arg177 and Asp171 via water molecules. An addi-
tional hydrophobic interaction is observed between
Val170 and the C5 position of C209. Within the DNAResults and Discussion
minor groove, Arg142 of L9 forms hydrogen bonds with
the N3 position of A239 and the O2 position of C249. TheOverall Structures
The structure of a complex comprised of the CBFa Runt backbone amides of Gly143 and Val170 interact with the
phosphate backbone in the minor and major grooves,domain and the CBFb core domain bound to a 26 bp
DNA fragment from the CSF-1R promoter, together with respectively. The L9-minor groove interaction seems to
be critical for DNA bending. CBFa-DNA binding is alsothe C/EBPb basic leucine zipper region homodimer, is
shown in Figures 1A–1C. The amino acid sequences supported by several nonspecific direct or water-medi-
ated interactions between the side chains and backboneof the CBFa Runt domain and the CBFb core domain
fragments, and the base sequence of the 26 bp and 16 of CBFa and the sugar-phosphate backbone of the DNA
(Figure 2D).bp DNA fragments used for crystallizations are shown
in Figure 2A. Note that the structures of DNA-bound To examine the specific functional roles of the CBFa
residues directly involved in binding to the DNA, weCBFa are very similar, with or without CBFb: the rms
deviation of the a carbon atoms was only about 0.28 A˚. carried out electrophoretic mobility shift assays (EMSA)
using various CBFa point mutants and found that allOverall foldings of CBFa and CBFb are consistent with
that previously reported (Berardi et al., 1999; Goger et (R80A, R142A, D171A, R174A, and R177A) but V170A
reduce or completely abolish DNA binding (Figure 4A),al., 1999; Huang et al., 1999; Nagata et al., 1999; Warren
et al., 2000): both the CBFa Runt domain and the CBFb which confirms that these residues all specifically recog-
nize the DNA via hydrogen bonds. Supporting our struc-core domain fold principally as b barrel architectures,
Structure of AML1/Runx-1(Runt Domain)-CBFb-DNA
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Figure 1. Overviews of the CBFa-b-C/EBPb-
DNA Quarternary Complex from Three Per-
spectives
Views from the front (A), from the side (B),
and from the top (C). Within CBFa, b strands,
and loops are depicted as red arrows and
pink tubes, respectively; within CBFb, a heli-
ces, b strands, and loops are depicted as
green ribbons, blue arrows, and cyan tubes,
respectively. The C-terminal region of the
C/EBPb homodimer containing the bZip do-
main is shown as yellow ribbons.
tural evidence, earlier results obtained using AML- or DNA and can be divided into two predominantly hydro-
philic interaction areas—one proximal to DNA (Area I)CCD-related mutants or artificial point mutants (Lenny
et al., 1995; Crute et al., 1996; Akamatsu et al., 1997a, (Figures 3A and 3D) and one distal (Area II) (Figures 3A
and 3C)—with an intervening hydrophobic area. Area I1997b; Lee et al., 1997; Osato et al., 1999; Zhou et al.,
1999; Zhang et al., 2000) show that mutations that dis- consists of b5, L5, and b10 of CBFa and b1, L1, L2, and
b3 of CBFb. A hydrogen bonding network is formed inrupt the folding architecture of CBFa, or those in which
DNA-recognizing residues are substituted (R80C, K83N, this area between the backbones and side chains of
Ala107, Tyr113, and Ser114 of CBFa and the side chainsR139Q, R174Q, and R177Q), diminish or abolish CBFa-
DNA binding. of Asn63, Arg33, and Lys28 of CBFb; the phenol ring of
Tyr113 also makes van der Waals contacts with Thr30
and Val58 of CBFb. In addition, the side chain of Thr149CBFa-CBFb Interactions
of CBFa is hydrogen bonded to the backbone of Asn63CBFb binds to CBFa at a site away from the DNA binding
of CBFb. Area I extends to the central hydrophobic re-site, such that the longitudinal axes of the barrel-shaped
gion situated between b5, b10, L10, b11, and L11 ofproteins are oriented perpendicularly (Figures 1A–1C,
CBFa and a2, b3, and L5 of CBFb, where Met106,3A, and 4F). At the CBFa-CBFb interface, the somewhat
Thr151, Phe153, Val159, and H163 of CBFa and Phe17,exposed b sheet region of CBFa, which is composed
Asn63 (methylene part), Leu64, and Ser65 (methyleneof b5, b10, and b11, is inserted into the space between
part) of CBFb are involved in van der Waals contacts.b3 and b5 of CBFb, which form the edges of a b sheet
Area II consists of L1, L10, and b11 of CBFa and the(Figure 3A), thereby stabilizing the two subunits. Com-
N terminus, a1, b3, b5, and L5 of CBFb. This area con-parison of the CBFa-CBFb interfaces in the free (Warren
tains a short, intermolecular, parallel b sheet, composedet al., 2000) and DNA-bound forms indicates that the
of b11 of CBFa and b5 of CBFb (Figures 2B and 2C),interface becomes more extended—and consequently
with hydrogen bonds between the backbones of Pro157more stable—upon binding to DNA, as evidenced by an
and Val159 of CBFa and Ile102 and Asn104 of CBFbincrease in the surface area buried between CBFa and
(Figure 3C). The hydrogen bonding network in the areaCBFb from 1900 A˚2 to 2190 A˚2 and an increase in the
around the parallel b sheet extends between the back-number of possible intersubunit hydrogen bonds from
bone and side chain of Thr161 of CBFa and the side10 to 16. Also, a slight difference of the relative positions
chain of Asn104 of CBFb. The parallel b sheet is alsobetween CBFa and CBFb is observed, when the back-
stabilized by van der Waals contacts between Pro156bone a carbons of the CBFa molecules in the CBFa-
and Gln158 (methylene part) of CBFa and Ile102 of CBFbCBFb complexes with and without DNA are superim-
on one side, and between Pro157 and Val159 of CBFaposed.
The CBFa-CBFb interface extends linearly from the and Gln67 (methylene part), Met101, Leu103, and Leu64
Cell
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Figure 2. Sequences, Foldings, and DNA Recognition
(A) Amino acid sequences of CBFa and CBFb with indications of their secondary structures; the nucleotide sequence of the 26 bp double-
stranded DNA fragment used for determining the structures of the CBFa-b-C/EBPb-DNA and CBFa-C/EBPb-DNA complexes; and the sequence
of the 16 bp DNA fragment used for determining the structure of the CBFa-DNA complex.
(B and C) Topology diagrams of the structures of CBFa (B) and CBFb (C). The first and last residue numbers of each secondary structure are
indicated. The notations A, B, C, C9, E, F, and G correspond to the b strands classified as being within the immunoglobulin fold. In (B), cyan,
green, and yellow circles depict the residues involved in specific DNA base recognition, nonspecific DNA backbone interactions, and water-
mediated interactions, respectively. In (C), the electron density of a section of L3 (residues 71 to 81) was not observed (dotted line).
(D) Schematic representation of DNA recognition by CBFa. Dashed and solid lines depict intermolecular hydrogen bonds and van der Waals
contacts, respectively. DNA base labels involved in direct interactions with amino acids are colored red. A DNA base label involved in water-
mediated base recognitions is colored green. DNA recognitions by the peptide backbone amide are noted as NH. Minor groove recognitions
are circled with magenta.
(E) A stereo view of the specific interactions between CBFa and DNA. Pink tubes show the CBFa peptide backbone. Dotted lines depict
intermolecular hydrogen bonds and water molecules are shown as red balls.
Structure of AML1/Runx-1(Runt Domain)-CBFb-DNA
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Figure 3. Stabilization Network between CBFa, CBFb, and DNA
(A) CBFa-CBFb heterodimer structure in complex with the DNA. Two predominantly hydrophilic interaction areas between CBFa and CBFb
(Areas I and II) are marked with dotted circles.
(B) Schematic representation of the stabilization network between CBFb (cyan), CBFa (pink), and DNA (gray).
(C and D) Stereo views highlighting the hydrogen bonding network among CBFa, CBFb, and DNA moieties at Area II (C) and Area I (D) within
the CBFa-b-C/EBPb-DNA complex. CBFa and CBFb are colored pink and cyan, respectively. Hydrogen bonds are depicted by black dotted
lines. To demonstrate the change in the conformation of CBFa caused by CBFb binding, parts of the CBFa structure as it occurs within the
CBFa-DNA complex (without CBFb) are superimposed in green.
Cell
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of CBFb on the other side, a network of van der Waals
contacts that extends all the way to the central hy-
drophobic region. Near this site, the side chain of Asn69
and backbone of Asp66 of CBFa are hydrogen bonded
to the backbone of Pro2 and side chain of Lys11 of
CBFb, respectively, and Pro68 of CBFa makes a van
der Waals contact with Val5 of CBFb, stabilizing the
N-terminal regions of both subunits.
Several CBFa point mutations that degrade or abolish
CBFa-CBFb heterodimerization have been described
(Lenny et al., 1995; Akamatsu et al., 1997a; Li and Ger-
gen, 1999). Some (e.g., N109D, F146Y, L148D, or Q158L)
impair CBFa-CBFb binding by disrupting the conforma-
tion of L5 or the overall folding architecture of CBFa,
which also affects its ability to bind to DNA. Others
(e.g., M106V or G108R) impair CBFa-CBFb binding by
specifically affecting the recognition residues at the
CBFa-CBFb interface. For instance, replacement of
Met106 with a b-branched valine would cause steric
hindrance between the branched methyl group of valine
and the methylene part of Asn63 of CBFb, while replace-
ment of Gly108 with arginine would cause steric hin-
drance between the arginine and the L2 main chain of
CBFb. In these cases, the mutants retain the capacity
to bind to the DNA.
The effects of several CBFb mutations on CBFa-CBFb
heterodimerization and their in vivo function were exam-
ined in a parallel study (Tang et al., 2000b). R3A, V4A,
G61A, Q67A, L103A, and N104A mutations all impair heter-
odimerization, as Arg3, Gln67, Leu103, and Asn104 are all
directly involved in CBFa-CBFb binding, as described
above (Figure 3C); the V4A mutation would be expected
to alter the folding structure of CBFb; and the G61A
mutation would cause steric hindrance between the gly-
cine and the Asn109 backbone of CBFa (Figure 3D).
Figure 4. Characterization of the CBFa and CBFb Mutants on DNAEffects of Amino Acid Mutations on CBFa-CBFb
Binding and CBFa-CBFb Heterodimerization, and Structural MapsHeterodimerization Detected by EMSA of Disease-Related Mutations
and Isothermal Titration Calorimetry
(A–E) Autoradiograph of polyacrylamide gels showing EMSA analy-
The effect of various CBFa and CBFb point mutations ses of CBFa binding to DNA in the absence or presence of CBFb;
on heterodimerization was further examined using the various CBFa and CBFb point mutants were used; fragment length
was the same as that used for crystallizations. DNA binding reac-EMSA and isothermal titration calorimetry (ITC) experi-
tions were carried out for 20 to 30 min at 208C in buffer containingments (Figures 4B–4E and Table 1). CBFa Y113A and
25 mM HEPES (pH 7.4), 50 mM KCl, 5 mM MgCl2, 0.5 mM EDTA,T149A mutations and CBFb V5A, N63A and N104A muta-
5% Ficol, 10 mM DTT, 0.2 mg/ml BSA, ,2.9 pM DNA, 2.5 nM wild-tions—all of which affect residues directly involved in
type or mutant CBFa, and 3 nM (B) or 100 nM (A and C) wild-type
the interactions between the two subunits—impaired or CBFb, or 3 nM (D) or 100 nM (E) mutant CBFb. The 16 bp DNA
abolished heterodimerization, confirming the functional fragment shown in Figure 2A was used for the binding assay. Poly-
acrylamide gel electrophoresis (15%, 120 V) was carried out at 208Croles of these residues described above. The CBFb
for 90 min.N63F mutant does not bind to CBFa due to steric hin-
(F and G) Structural maps of CBFa point mutations occurring indrance involving the introduced bulky phenyl ring. By
acute myelogenous leukemia and related diseases (F) and in cleido-contrast, the CBFa-CBFb interactions are only slightly
cranial dysplasia (G). The mutated residues are shown in green ball
impaired by D110A/E111A or K144M mutation of CBFa. and stick presentations. The peptide backbones of CBFa and CBFb
This effect may be a consequence of destabilization of are depicted as pink and cyan tubes, respectively.
the conformation of L5 caused by perturbation of the
polar environment, which in wild-type CBFa is formed
by the side chains of Asn109, Asp110, Glu111, and binding, nor does the D66A mutation; the latter likely
slightly enhances CBFa-CBFb interactions, probablyLys144. In the case of the CBFa N109A mutant, destabili-
zation of the conformation of the L5 loop is more critical, due to relief of the steric hindrance between Asp66 of
CBFa and Asn104 of CBFb.because in wild-type CBFa, the side chain of Asn109 is
well stabilized by two hydrogen bonds with the back-
bones of Ser145 and Gly108. The N109A mutation thus Thermal Stabilization of CBFa upon CBFb
and DNA Bindingcauses an almost total loss of the heterodimerization.
The CBFa R142A mutation, which is the mutation of a To examine the conformational stabilization of CBFa by
CBFb and DNA, we measured the thermal stabilitiesDNA-recognizing residue, does not impair CBFa-CBFb
Structure of AML1/Runx-1(Runt Domain)-CBFb-DNA
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domain, all of which are prone to be flexible. L3, L9, andTable 1. Dissociation Constants of CBFa or CBFa Mutants
L12 are mainly involved in DNA recognition (Figures 2BBinding to CBFb or CBFb Mutants
and 2E), and the relative orientations of L3 and L12 areCBFa CBFb KD (3 1029 M)
weakly fixed by the adjacent short parallel b sheet between
WT WT 26.1 6 6.5 b3 and b12, facilitating DNA recognition at the major
D66A WT 17.7 6 6.7 groove. L9, which interacts with the minor groove, is con-
N109A WT 280.5 6 45.4
sidered to be most flexible—and thus the least stable,D110A/E111A WT 50.5 6 11.7
especially in the absence of CBFb binding—due to theY113A WT 115.9 6 29.7
presence of three glycine residues. The relative posi-R142A WT 18.9 6 3.6
K144M WT 44.8 6 6.2 tions of b12–L12 and L9 are important for efficient DNA
T149A WT 152.4 6 39.0 binding, because CBFa catches the sugar-phosphate
WT N63A 146.2 6 55.1 backbone ridge of the DNA from both sides: the major
WT N104A 281.2 6 127.0
groove interacts with the b12–L12 arm and the minor
groove with L9, where the Lys167 side chain of b12 and
the Gly143 backbone of L9 recognize the same phosphate,
of the CBFa Runt domain in free, CBFb-bound, DNA- and the backbone of Val170 of L12 recognizes the adjacent
bound, and CBFb- and DNA-bound states in CD and phosphate. In the presence of CBFb, networks of hydro-
UV melting experiments (Table 2). In the absence of gen bonds between L11 and L9 and between L9 and L5
CBFb and DNA, the melting point (Tm) of the CBFa Runt would stabilize the b12–L12 arm and L9.
domain is 448C. When bound to CBFb or DNA, however, As described above, CBFb interacts with CBFa via
the Tm of CBFa increases to 548C and 538C, respec- two predominantly hydrophilic regions—Areas I and II.
tively. And when both CBFb and DNA are bound, the Here, we describe how their stabilization affects the
Tm of CBFa is 608C. Thus, the thermal stability of CBFa conformations of the flexible loops in contact with the
in the absence or presence of DNA is increased upon DNA. In Area I (Figures 3A, 3B, and 3D), CBFb mainly
binding CBFb, and CBFa is fully stabilized upon binding interacts with L5 of CBFa, which has an extensive net-
both CBFb and DNA. Moreover, the transition enthalpy work of hydrogen bonds with L9. Within that network,
of the DNA-bound CBFa is significantly increased from Asp110 and Glu111 of L5 make salt bridges with Lys144
430 to 930 kJ mol21 in the presence of CBFb. of L9, and the side chain of Asn109 of L5 is hydrogen
bonded to the backbone of Ser145 of L9. This hydrogen
Mechanism for the Regulation of CBFa-DNA bonding network extends to the anti-parallel b sheet
Binding by CBFb between b5 and b10 of CBFa, where the backbone of
CBFa-DNA binding is enhanced several fold in the pres- Ala107 and the side chain of Thr149 are hydrogen
ence of CBFb (Ogawa et al., 1993; Gu et al., 2000; Tang bonded to the backbone and side chain of Asn63 of
et al., 2000a), an effect confirmed by the present analysis CBFb, supporting the L5–L9 interactions. As a result,
(Figures 4A–4E). To examine the regulation of CBFa- CBFb stabilizes L9 such that it facilitates interactions
DNA binding by CBFb in more detail, we compared the between the backbone amide of Gly143 of CBFa and a
structure of the CBFa-b-C/EBPb-DNA complex with DNA backbone phosphate and between the side chain
those of the CBFa-C/EBPb-DNA and CBFa-DNA com- of Arg142 of CBFa and the N3 position of A239 and O2
plexes, which lack the CBFb subunit. Somewhat surpris- position of C249 of the DNA. In the absence of CBFb—
ingly, CBFb binding causes no dramatic structural i.e., within the structures of the CBFa-DNA and CBFa-
changes in the CBFa Runt domain, which implies that C/EBPb-DNA complexes—the hydrogen bond between
CBFb does not alter the overall conformation of the Ser145 and Asn109 and the salt bridges between
CBFa Runt domain, but only stabilizes it in a conforma- Lys144, Asp110, and Glu111 are not observed, indicat-
tion suitable for DNA binding. ing insufficient stabilization of L9 and L5. Furthermore,
Facing toward the DNA are four loops (L3, L5, L9, and comparison of the structures of CBFa-b-C/EBPb-DNA
and CBFa-b (Warren et al., 2000) revealed that the back-L11) and a C-terminal linker (L12) of the CBFa Runt
Table 2. Thermodynamic Parameters of the Thermal Transitions for the Free or Complexed Forms of CBFa, CBFb, and DNA
(assignment of transition component)*
CBFa CBFb DNA
Tm.1 DHv.1 Tm.2 DHv.2 Tm.3 DHv.3
(8C) (kJ/mol) (8C) (kJ/mol) (8C) (kJ/mol)
CBFa CD220 44.4 303
CBFb CD220 49.6 588
CBFa1CBFb UV215 53.9 833 57.8 489
DNA UV260 65.7 305
DNA1CBFa UV260 52.5 432 66.0 390
DNA1CBFa1CBFb CD220 60.0 899 58† † ‡ ‡
UV260 59.8 927 ‡ ‡ 65.2 480
* The assigned component may involve the interfaces with the neighboring components thermodynamically. The melting temperature (Tm)
and van’t Hoff enthalpy (DHv) are listed for each component.
† The value is ambiguous or not determined due to weak appearance of the transition.
‡ The transition was not observed.
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bone conformations of Arg142–Lys144 of L9 and the lation of CBFa-CBFb binding by the DNA; when the
CBFa-CBFb heterodimer binds to DNA, the entire hydro-Arg174-C terminus of L12 in CBFa differ within the com-
plexes, indicating that optimal hydrogen bonding in the gen bonding network shown in Figures 3B–3D is com-
pleted by the conformational stabilization of the regionsarea around L5 and L9 of CBFa is not achieved until
both CBFb and DNA are bound. around L5 and b10 via Area I, around b11–L11 and L1
via Area II, around L9 via the DNA minor groove, andIn Area II (Figures 3A–3C), CBFb interacts mainly with
b11 but also with L1 of CBFa; b11 extends through L11 around b12–L12 via the DNA major groove.
to the b12–L12 segment, which interacts with the DNA,
and L1 extends through b2–L2 to the b3–L3 segment, Effects of Amino Acid Mutations on the Allosteric
which also interacts with the DNA. Here, by following Regulation Mechanism, Detected by EMSA
the intermolecular parallel b sheet between b5 of CBFb and Surface Plasmon Resonance
and b11, one observes that the side chain of Asn104 of We next carried out a series of EMSA experiments using
CBFb makes hydrogen bonds with the backbone and CBFa and CBFb point mutants with the aim of better
side chain of Thr161 of b11. The stabilized Thr161 back- understanding the facilitation of CBFa-DNA binding by
bone is also hydrogen bonded to the backbone of Asp66 CBFb (Figures 4A–4E). In these experiments, however,
of L1, while the Asp66 side chain conformation is altered the effective concentration of CBFa was reduced in the
by the steric effect of the side chain of Asn104 of CBFb, absence of CBFb due to precipitate formation during
resulting in formation of a hydrogen bonding network incubation time, resulting in an apparent enhancement
with the backbone of Thr161 and the backbone and side of CBFa-DNA binding which is unrelated to the “real”
chain of His163 of L11. The His163 side chain is also allosteric control by CBFb. Therefore, to examine the
stabilized by the central hydrophobic region of the allosteric regulation of CBFa-DNA binding by CBFb in
CBFa-CBFb interface. Moreover, the backbones of a more precise and quantitative fashion, we carried out
Tyr162, Arg164, Ala165, Ile166, and Ile168 from the L11– the surface plasmon resonance (SPR) experiments in
b12 region are hydrogen bonded to the backbone of the absence and presence of CBFb (Table 3).
Leu148, the side chain of Thr147, and the backbones Although point mutations affecting residues that di-
of Phe146 and Ser140 from the L9–b10 region, which is rectly interact with the DNA impaired CBFa-DNA bind-
also stabilized by CBFb via Area I. Consequently, the ing, that binding is still enhanced in the presence of
L11–b12 region is stabilized by both Areas I and II. In CBFb, the R174A mutant being the only exception (Fig-
this way, CBFb stabilizes the b11–L11–b12 segment ure 4A). In the point mutations affecting residues in-
such that the side chain of Lys167 and the backbone volved in the allosteric regulation of CBFa-DNA binding
of Val170 efficiently interact with DNA backbone phos- by CBFb, most of these affect CBFa-CBFb binding (Fig-
phates, and residues of L12 (Asp171, Arg174, and ures 4B–4E). For example, the CBFa N109A mutation
Arg177) interact with the DNA bases. In addition, around and the CBFb N63F and N104A mutations almost com-
the L1 region, the side chain of Asn69, which interacts pletely disrupt the allosteric regulation of CBFa-DNA
with the Pro2 backbone of CBFb, becomes hydrogen binding solely by abolishing the interaction between
bonded to the backbone of Gly95 and the side chain of CBFa and CBFb. The N109A mutant also significantly
Gln158 to bridge L4 and b11. Acting in concert, the diminished DNA binding, most likely due to destabiliza-
interactions just described enable CBFa to grip the DNA tion of the L5 and L9 loops caused by collapse of the
molecule at both the major and minor grooves. hydrogen bonding network between them. By contrast,
in the case of the CBFa Y113A and T149A mutants
and the CBFb N63A mutant, the allosteric regulationNMR Data Support the Notion of Allosteric
Regulation of CBFa-DNA Binding of CBFa-DNA binding is only partially impaired due to
moderate degradation of the interaction between CBFaThe allosteric regulation of CBFa-DNA binding by CBFb
is well supported by previously described NMR data. and CBFb (Figures 4B and 4D; Table 1), and this impair-
ment can be largely overcome by adding excess CBFbUpon binding CBFb, large chemical shifts changes of
the backbone amide protons and nitrogens of CBFa- (Figures 4C and 4E; Table 3). Finally, in the case of the
CBFa D66A, D110A, E111A, and D110A/E111A mutants,DNA are observed in the L1, b5–L5, b10, and b11–L11
regions (Nagata et al., 1999; Tang et al., 2000a), all of not only is the facilitation of CBFa-DNA binding by CBFb
not impaired, in some cases it is actually further en-which participate in the regulation of CBFa-DNA binding
by CBFb. It is also reported that in the DNA-free state, hanced, indicating that the salt bridge contributions of
Asp66, Asp110, and Glu111 are not critically importantthe backbone amide signals from residues in the area
around L5 and L9–b10 and from Lys167 of CBFa are not for the enhancement. In fact, although it was necessary
to collect the SPR data in the presence of a relativelyobserved due to conformational exchange contributions
(Perez-Alvarado et al., 2000). Even in the DNA-bound high salt concentration (180 mM NaCl), which might be
expected to weaken salt bridge interactions and thusstate, the backbone amide signals from the residues in
the area around L11 exhibit exchange broadening that diminish the protein’s affinity for DNA, wild-type CBFa-
DNA binding is enhanced by CBFb to an extent similaris removed upon CBFb binding (Tang et al., 2000a),
indicating that slow conformational fluctuations in the to that seen in gel shift experiments carried out in the
presence of a relatively low salt concentration (Gu etpeptide backbone in the area around L11 still occur
within the CBFa-DNA complex, and that such fluctua- al., 2000; Tang et al., 2000a). It is therefore concluded
that the CBFa and CBFb residues involved in formingtions are suppressed after CBFb binding. These findings
all support the notion of allosteric regulation of CBFa- hydrogen bonds with the peptide backbone of CBFa in
Areas I and II (e.g., N109 of CBFa and N63 and N104 ofDNA binding by CBFb, in other words, of allosteric regu-
Structure of AML1/Runx-1(Runt Domain)-CBFb-DNA
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Table 3. Kinetic and Dissociation Constants of CBFa or its Mutants Binding to DNA in the Absence and Presence of CBFb
or its Mutants
CBFa CBFb KD (31029 M) ka (3 105 M21 s21) kd (3 1023 s21)
WT (2) 35.8 6 0.6 2.08 6 0.19 7.45 6 0.76
WT WT 7.56 6 0.47 3.89 6 0.25 2.93 6 0.02
D66A (2) 53.2 6 2.6 1.09 6 0.13 5.77 6 0.57
D66A WT 8.14 6 0.19 3.29 6 0.14 2.68 6 0.15
N109A (2) 160 6 9 1.36 6 0.19 22.0 6 2.0
N109A WT nda nda nda
D110A (2) 28.6 6 0.19 2.17 6 0.20 6.20 6 0.43
D110A WT 4.19 6 0.51 6.42 6 0.63 2.66 6 0.20
E111A (2) 28.2 6 1.27 2.04 6 0.19 5.73 6 0.36
E111A WT 3.27 6 0.51 6.23 6 0.31 1.97 6 0.13
D110A/E111A (2) 28.6 6 0.29 1.72 6 0.19 4.85 6 0.55
D110A/E111A WT 3.13 6 0.17 4.87 6 0.50 1.52 6 0.15
Y113A (2) 37.7 6 1.9 2.37 6 0.45 8.91 6 0.76
Y113A WT 9.92 6 0.47 3.10 6 0.25 3.16 6 0.25
R142A (2) 63.9 6 3.4b 1.17 6 0.1b 7.51 6 0.71b
R142A (2) nda,b nda,b nda,b
K144M (2) 489 6 12.2c nda nda
K144M (2) 34.0 6 2.8d 1.61 6 0.13d 5.48 6 0.47d
K144M WT 35.2 6 3.7d 1.56 6 0.22d 5.52 6 0.85d
T149A (2) 37.1 6 1.4 1.59 6 0.34 5.90 6 1.00
T149A WT 7.02 6 0.92 4.67 6 0.47 3.26 6 0.31
WT N63A 15.1 6 1.4 2.82 6 0.34 4.26 6 0.58
WT N104A nda nda nda
a Not determined from the sensorgram, because the increase in the RU was not monophasic or was too small.
b These values were obtained in the presence of 100 mM NaCl instead of 180 mM NaCl.
c This value was calculated using Scatchard analysis.
d These values were obtained in the presence of 140 mM NaCl instead of 180 mM NaCl.
CBFb) play particularly important roles in stabilizing the critical interactions mediating the allosteric regulation
by CBFb. In that regard, it is notable that the loop inter-hydrogen bonding network of the CBFa-CBFb interface
(Figures 3C and 3D). acting with the minor groove uses hydrogen bonds sen-
sitive to the backbone conformation of the loops forThe CBFa R142A and K144M mutants are associated
with markedly diminished DNA binding due to disruption regulation of DNA binding. It is thus concluded that the
conformation and stability of the backbone of the L9of hydrogen bonds between the affected residues and
the DNA. In the R142A mutant, an arginine that specifi- loop, which binds to the minor groove, is a key determi-
nant in the regulation of CBFa-DNA binding by CBFb.cally recognizes DNA bases is replaced by alanine,
somewhat impairing CBFb-mediated facilitation of CBFa-
DNA binding (Figures 4A–4C). Some enhancement of Comparison of Regulation of CBFa-DNA Binding
with that of Other Transcription Factors’ DNA Bindingthe binding of the R142A mutant to DNA is detected
in the presence of excess CBFb, though we did not CBFa belongs to a group of transcriptional regulatory
proteins that possess an immunoglobulin fold in theirquantitatively evaluate these SPR data due to the non-
monophasic behavior of the interaction (data not DNA binding domains—these include NFAT, STAT1,
STAT3b, T-domain, p53, and NF-kB (Cho et al., 1994;shown).
The K144M mutant is the most remarkable. Its signifi- Ghosh et al., 1995; Mu¨ller et al., 1995; Cramer et al.,
1997; Mu¨ller and Herrmann, 1997; Becker et al., 1998;cantly diminished DNA binding activity is most likely due
to a conformational change and destabilization of the Chen et al., 1998a, 1998b, 1998c, 1998d; Zhou et al.,
1998). These proteins all bind to DNA mainly using loopsL9 backbone caused by replacement of the polar lysine
side chain—normally inserted into a hydrophilic environ- and a C-terminal linker located on the same end of a b
barrel, though their three-dimensional orientations varyment formed by Asn109, Asp110, and Glu111 from L5—
with a bulky hydrophobic methionine side chain. The widely, leading to differences of their respective target
DNA sequences. Since we now have a better under-effect of such a mutation would be expected to cause
conformational changes in the backbone of the next standing of the mechanism by which CBFb regulates
CBFa-DNA binding, it becomes of great interest to com-residue, Gly143, whose backbone amide normally inter-
acts with a DNA backbone phosphate, thereby reducing pare that mechanism with those regulating the binding
to DNA of other proteins containing immunoglobulinDNA binding. Although CBFb binding activity is only
slightly impaired in this mutant (Table 1), no facilitation folds.
Within the NFAT-Fos-Jun-DNA complex (Chen et al.,of CBFa K144M-DNA binding is observed, even when
virtually all the mutant is bound to CBFb (Table 3). This 1998b), the minor groove–interacting loop (E9F loop) of
NFAT is stabilized by Fos-Jun heterodimer. This modefinding strongly supports the proposed mechanism, in
which a hydrogen bond between the Gly143 backbone of interaction has a distant resemblance to the CBFb-
mediated stabilization of L9 of CBFa via L5. Further-amide and a DNA backbone phosphate is one of the
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Table 4. Summary of X-Ray Experiments
Complex CBFa-DNA CBFa-C/EBPb-DNA CBFa-b-C/EBPb-DNA
Crystal data
a (A˚) 51.1 102.2 121.1
b (A˚) 104.1 109.3 163.6
c (A˚) 116.2 127.4 109.3
Space group P212121 P21212 C2221
Data collection
Wavelength (A˚) 1.0 0.7085 1.0 1.0398 1.0388
Resolution (A˚) 20–2.65 30–3 20–3 20–3 20–3
Reflections
total 61,764 117,670 66,989 63,748 65,319
unique 17,550 26,407 21,113 20,972 20,992
Completeness (%) 94.5 91.3 97.1 96.5 96.7
I/s( I) 26.6 13.0 15.5 15.9 16.4
Rsym 0.047 0.066 0.062 0.057 0.058
MAD phasing (3.1 A˚ resolution)
Rcullis, dispersive/anomalous —/0.69 0.65/0.64 0.69/0.64
Phasing power, dispersive/anomalous —/1.24 0.97/1.40 0.83/1.42
Figure of merit (all) 0.42
Refinement
Rcryst/Rfree (5% of reflections) 0.223/0.263 0.244/0.313 0.247/0.299
Rms deviations
bonds (A˚)/angles (8) 0.008/1.38 0.007/1.27 0.007/1.31
Ramachandran plot (% of residues in regions)
core 83.2 86.5 86.7
additionally allowed 16.3 12.6 12.7
generously allowed 0.5 0.9 0.6
disallowed 0.0 0.0 0.0
more, when we superimpose NFAT within the NFAT- (Batchelor et al., 1998). In this case, the minor groove–
interacting helix of GABPa is stabilized by the ankyrin-Fos-Jun-DNA complex and CBFa within the CBFa-b-
C/EBPb-DNA complex using their conserved b strand like repeats of GABPb. From the structural evidences
of the protein-DNA complexes explained above, we canregions for fitting, Fos-Jun partially overlaps CBFb.
Within NF-kB (p50, p52, and p65)-DNA complexes find that stabilization of the protein backbone amide–
DNA phosphate interaction at the protein-DNA minor(Ghosh et al., 1995; Cramer et al., 1997; Chen et al.,
1998a, 1998d), the “mobile” insert region, which may groove interface appears to be a common feature of
mechanisms in which a regulatory protein, having orinteract with other DNA binding proteins (Cramer et al.,
1997), could stabilize the interaction between the protein not having the DNA binding activity, affects its partner
protein-DNA interaction.and the DNA minor groove. When the NF-kB N-terminal
domain within the NF-kB (p50)-DNA complex and CBFa
within the CBFa-b-C/EBPb-DNA complex are superim- The Relationship between the Structure of the
CBFa-CBFb Heterodimer Bound to the DNAposed, the insert region of p50, which is also contained
in p52 and p65, overlaps CBFb, suggesting the regula- and the Amino Acid Mutations in Related Diseases
AML1/Runx-1 and CBFb are the most frequently mu-tory role of the insert region is similar to that of CBFb.
Within the p53-DNA complex (Cho et al., 1994), the minor tated molecules in acute leukemia and related diseases
(Cleary, 1999; Speck et al., 1999; Lutterbach and Hiebert,groove–interacting loop (L3), which sandwiches the DNA
sugar-phosphate ridge with the major groove–inter- 2000), whereas CBFA1/Runx-2 is mutated in CCD, a
congenital osseous abnormality (Quack et al., 1999;acting b strand (S10), is stabilized by zinc coordination
such that the zinc atom can modulate the interaction Zhou et al., 1999; Zhang et al., 2000). The majority of
mutations associated with acute leukemia are causedbetween p53 and the DNA (Rainwater et al., 1995). Inter-
estingly, Arg248 in L3, Arg273 in S10 and some point by sporadic chromosomal translocations, resulting in
conversion of CBFa-CBFb from a heterodimeric tran-mutations destabilizing the L3 conformation are very
frequently mutated in human tumors (Hollstein et al., scriptional activator to a transcriptionally repressive fu-
sion protein (Cleary, 1999; Speck et al., 1999; Lutterbach1996).
Thus, a number of transcriptional regulatory factors and Hiebert, 2000).
In addition, acute leukemias and related diseases as-possessing immunoglobulin folds in their DNA binding
domains also seem to possess related mechanisms— sociated with biallelic and heterozygous point mutations
of AML1/Runx-1 have also been reported (Osato et al.,mediated by other transcription factors or by chemical
modifications—that regulate DNA binding by affecting 1999; Werner et al., 1999; Barton and Nucifora, 2000;
Imai et al., 2000; Preudhomme et al., 2000). In the caseareas of interaction sandwiched between the protein
and the DNA, although the detailed mechanisms differ. of biallelic mutations, no functional AML1/Runx-1 allele
remains; in the case of heterozygotes, the DNA bind-Analogous to CBFs, the Ets domain transcription factor
GABP also consists of a subunit that binds to the DNA ing activity of AML1/Runx-1 from one allele is impaired,
with AML1/Runx-1-CBFb heterodimerization activity re-(GABPa) and a regulatory subunit that does not (GABPb)
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combined with density modification, produced a good quality elec-tained. As the hereditary case, some pedigrees having
tron density map, enabling the main chain to be clearly traced andheterozygous point mutation of AML1/Runx-1 resulting
most of the side chains of the proteins to be well fitted. The orienta-in a familial platelet disorder with a propensity to develop
tions of the DNA atoms were also confirmed using complexes con-
into acute myelogenous leukemia (FPD/AML) has also taining three heavy atom derivatives of the DNA fragments in which
been reported (Song et al., 1999). four, five, or six deoxythymidines were replaced with 5-iodo deoxy-
uracils at the corresponding positions. A model was built usingBased on the three-dimensional structure of the
TURBO-FRODO software and refined using standard protocols ofCBFa-CBFb heterodimer bound to the DNA, point muta-
CNS version 0.9a (Bru¨nger et al., 1998). The structures of CBFa-C/tion sites in the heterozygous cases are mapped exclu-
EBPb-DNA and CBFa-DNA were solved by the molecular replace-sively to regions of the CBFa-DNA interface (Figure 4F).
ment method using the corresponding fragments of the refined
It is readily apparent that these mutations impair the structure of CBFa-b-C/EBPb-DNA as a search model and then re-
capacity of CBFa to bind to DNA without affecting the fined using CNS. The crystals of the latter two complexes contained
two complex molecules in an asymmetric unit. The statistics usedoverall folding architecture of CBFa or CBFa-CBFb het-
for the final refinement and for assessing the quality of the refinederodimerization, which could explain their dominant-
structures are summarized in Table 4.negative behavior (Imai et al., 2000). In contrast, CBFA1/
Runx-2 point mutations associated with CCD are
ITC Experimentsthought to affect the folding architecture of CBFa and
ITC measurements were carried out using a MicroCal MCS-ITC calo-thus impair both DNA binding and heterodimerization
rimeter at 258C. A 0.015 mM solution of CBFa was titrated using 8
(Figure 4G), resulting in haploinsufficiency of CBFA1/ ml aliquots of 0.16 mM CBFb solution. For both proteins, the buffer
Runx-2 (Quack et al., 1999; Werner et al., 1999; Zhou et solution contained 10 mM HEPES (pH 7.4), 180 mM NaCl, and
0.005% Tween 20. The dilution enthalpy of CBFb was subtractedal., 1999; Barton and Nucifora, 2000; Zhang et al., 2000).
from the titration data.
Conclusions
CD and UV Melting Experiments
Thermal denaturation of CBFa, CBFb, DNA, and their complexesWe have presented compelling structural evidence of
was measured with both CD and UV while increasing the tempera-
the mechanism by which CBFa recognizes DNA and ture at a rate of 0.75 K/min using a Jasco J-630 spectropolarimeter
the relationship between the structure of the resultant and a Shimadzu UV-1200 spectrometer. Samples were dissolved in
complex and such CBFa mutation–related diseases as 50 mM potassium phosphate buffer (pH 7.5) containing 50 mM KCl
and 10 mM DTT. The concentration of each sample was 0.025 mM.acute leukemias and CCD. We have also clarified the
Data were collected using cylindrical quartz cuvettes with a 0.2mode of interaction between CBFb and CBFa and the
mm path-length, and the temperature was controlled with a watermechanism by which the former regulates the binding
circulation system. Changes in ellipticity were monitored at 220 nm,
of the latter to DNA. CBFa-DNA binding is apparently while changes in absorbance were monitored at 260 nm and 215
modulated by CBFb through stabilization of CBFa re- nm for the samples with and without DNA, respectively.
gions that bind to the major and minor grooves of the
DNA. Although the higher-order structures of only a few Surface Plasmon Resonance
transcription factor-DNA complexes are known, the A BIAcore 2000 biosensor system (Pharmacia Biosencer, Uppsala)
was used to measure the interaction between CBFa and a 21 bppresent findings shed light on key aspects of transcrip-
DNA fragment (59-CAAACTCTGTGGTTGCCTTGC-39) derived fromtion factor assembly, which should be useful for future
the CSF-1R promoter. The biotinated DNA was bound to the biosen-analyses of cooperative transcription factor systems.
sor chip SA as a ligand via streptavidin pre-immobilized to dextran
of the chip surface. The ligand was diluted to 0.2 mM in 10 mM
Experimental Procedures HEPES buffer (pH 7.5) containing 300 mM NaCl and 0.005% Tween
20, and applied to the sensor chip surface at a rate of 5 ml/min until
Plasmid Construction, Bacterial Expression, Protein nearly 400 resonance units (RU) were obtained. The running buffer
Purification, Crystallization, and X-Ray Diffraction was the same as in the ITC experiments, and as analytes, CBFa or
The cDNA fragments encoding regions of mouse AML1/Runx-1 its mutants (except R142A and K144M, for which 100 and 140 mM
(Gly60-Lys182) and the CBFb (Met1-Gln141) were amplified and NaCl were used, respectively) were diluted to various concentrations
digested to generate the EcoRI-BamHI cDNA fragments, which were in the same buffer and then injected over the immobilized ligand at
then subcloned into pBS-KS vector, sequenced, and inserted as a rate of 15 ml/min until the injected volume reached 250 ml. For the
NdeI-BamHI fragments into pAR2156 vector. In some cases, site- experiments with CBFb, 500 nM CBFb or its mutant was added to
directed mutagenesis was then carried out using a QuikChange the CBFa solutions. After that, the dissociation of the analytes was
Site-Directed Mutagenesis kit (STRATAGENE) to make point muta- measured by injecting the running buffer alone. All experiments were
tions. The resultant pAR2156 plasmids containing inserts encoding performed at 258C. Data were analyzed with BIAevaluation version
the CBFa and CBFb fragments or their point mutants were intro- 2.1 using a nonlinear least squares method to obtain the association
duced into the BL21(DE3) cells for overexpression of their products. and dissociation rate constants (ka and kd, respectively). The equilib-Sample preparation, crystallization, cryoprotection of native and rium dissociation constants (KD) were calculated from the equationheavy atom derivative crystals, and diffraction data collections on KD 5 kd / ka or from Scatchard analysis.a RIKEN beamline BL45XU and a public beamline BL41XU at
SPring-8 (Harima, Japan) have been described elsewhere (Tahirov
Acknowledgmentset al., 2001).
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